The global proteinase activated receptor market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Proteinase-activated receptors (PARs) are a subfamily of G protein-coupled receptors (GPCRs). These receptors have four members which include PAR1, PAR2, PAR3 and PAR4. These receptors play critical applications in hemostasis, thrombosis, embryonic development, wound healing, inflammation and cancer progression. The major factor driving the growth of the global proteinase activated receptor market is the rising prevalence of cancer across the globe.
Get Free Sample link @ https://www.omrglobal.com/request-sample/proteinase-activated-receptor-market
According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Additionally, the most common cancers include breast cancer, lung and bronchus cancer, and leukemia, among others. In men, prostate, lung, and colorectal cancers will account for an estimated 43% of all cancers diagnosed while for women, the three most common cancers include breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in women in 2020.
Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Hence, the rising prevalence of cancer is increasing the demand for proteinase activated receptors to treat cancer progression which in turn is driving the growth of the market. Some major players in the market include Merck & Co., Inc., and Heptares Therapeutics Ltd., among others.
Full report of Proteinase Activated Receptor Market available @ https://www.omrglobal.com/industry-reports/proteinase-activated-receptor-market
Market Coverage
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Merck & Co., Inc., and Heptares Therapeutics Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Proteinase Activated Receptor Market Report by Segment
By Type
- PAR1
- PAR2
- PAR3
- PAR4
By Application
- Hemostasis
- Hrombosis
- Embryonic Development
- Wound Healing
- Inflammation
- Cancer
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/proteinase-activated-receptor-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
